| Bristol-Myers Squibb SA - Camzyos 5 mg, Hartkapseln | | 68477 | | 02 | | Camzyos 5 mg | | Hartkapseln | | C01EB24 | | Mavacamten | | 25.04.2023 | | |
| | Composition | | mavacamtenum 5 mg, silica colloidalis hydrica, mannitolum, hypromellosum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), ammoniae solutio concentrata, pro capsula corresp. natrium 1.05 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| Mavacamtenum | 5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Mavacamtenum | 5 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | Ammoniae Solutio Concentrata | | | | Carmellosum Natricum Conexum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Hypromellosum | | | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Mannitol | | | | Propylenglycol | | | | Silica Colloidalis Hydrica | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 28 | 1403.91 | 1602.80 | B | LS | Non |
|
|
